News
News
- PTA-News: Dr. Hönle AG: Restructuring of the Management Board of Dr. Hönle AG
05/16/2022 / 11:45 - pressetext - PTA-News: Dr. Hönle AG: Hönle increases its operating result by 14% to € 7.7 million in six months
05/12/2022 / 08:00 - pressetext - PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 - 117 WpHG
05/11/2022 / 19:30 - pressetext - PTA-DD: Dr. Hönle AG: Managers' transactions announcement according to article 19 MAR
03/31/2022 / 15:35 - pressetext - PTA-PVR : Dr. Hönle AG: Correction of a Release according to article 40 para. 1 WpHG from 28.02.2022
03/23/2022 / 14:30 - pressetext - PTA-News: S&T AG: SUPERVISORY BOARD APPOINTS COMPLIANCE BOARD
03/18/2022 / 15:00 - pressetext - NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
03/08/2022 / 08:00 - GlobeNewswire - PTA-PVR : Dr. Hönle AG: Correction of a Release according to article 40 para. 1 WpHG from 28.02.2022
02/28/2022 / 15:30 - pressetext - PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
02/28/2022 / 14:40 - pressetext - Europe tumbles at close as Russian attacks continue
02/24/2022 / 17:33 - TeleTrader